DE69928110D1 - Trägerhilfstoff - Google Patents

Trägerhilfstoff

Info

Publication number
DE69928110D1
DE69928110D1 DE69928110T DE69928110T DE69928110D1 DE 69928110 D1 DE69928110 D1 DE 69928110D1 DE 69928110 T DE69928110 T DE 69928110T DE 69928110 T DE69928110 T DE 69928110T DE 69928110 D1 DE69928110 D1 DE 69928110D1
Authority
DE
Germany
Prior art keywords
support material
material help
help
whiteness
trehalose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69928110T
Other languages
English (en)
Other versions
DE69928110T2 (de
Inventor
Kazuhiro Oobae
Etsuo Kamada
Shun Ichi Gomi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Asahi Kasei Chemicals Corp
Original Assignee
Asahi Kasei Chemicals Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asahi Kasei Chemicals Corp filed Critical Asahi Kasei Chemicals Corp
Application granted granted Critical
Publication of DE69928110D1 publication Critical patent/DE69928110D1/de
Publication of DE69928110T2 publication Critical patent/DE69928110T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1617Organic compounds, e.g. phospholipids, fats
    • A61K9/1623Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
DE69928110T 1998-07-15 1999-07-13 Trägerhilfstoff Expired - Lifetime DE69928110T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP20029598 1998-07-15
JP20029598 1998-07-15
JP32356098 1998-11-13
JP32356098 1998-11-13
PCT/JP1999/003775 WO2000003735A1 (fr) 1998-07-15 1999-07-13 Excipient

Publications (2)

Publication Number Publication Date
DE69928110D1 true DE69928110D1 (de) 2005-12-08
DE69928110T2 DE69928110T2 (de) 2006-07-27

Family

ID=26512084

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69928110T Expired - Lifetime DE69928110T2 (de) 1998-07-15 1999-07-13 Trägerhilfstoff

Country Status (10)

Country Link
US (1) US6699845B2 (de)
EP (1) EP1097722B1 (de)
JP (1) JP4748627B2 (de)
KR (1) KR100421264B1 (de)
CN (1) CN1185013C (de)
AT (1) ATE308343T1 (de)
AU (1) AU743109B2 (de)
CA (1) CA2337015C (de)
DE (1) DE69928110T2 (de)
WO (1) WO2000003735A1 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7407955B2 (en) 2002-08-21 2008-08-05 Boehringer Ingelheim Pharma Gmbh & Co., Kg 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
US20040131672A1 (en) * 2003-01-07 2004-07-08 Nilobon Podhipleux Direct compression pharmaceutical composition containing a pharmaceutically active ingredient with poor flowing properties
EP1460080A1 (de) * 2003-03-21 2004-09-22 Cargill Incorporated Direkt komprimierbare Trehalose in fester Form
CN1764388B (zh) * 2003-03-26 2010-05-05 株式会社林原生物化学研究所 非糖质成分的粉末化方法及粉末化基剂
DE102004054054A1 (de) 2004-11-05 2006-05-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verfahren zur Herstellung chiraler 8-(3-Amino-piperidin-1-yl)-xanthine
JP2007131587A (ja) * 2005-11-11 2007-05-31 Activas Pharma:Kk キノリノン誘導体を有効成分とする医薬組成物、及びその製造方法
EP1962806B1 (de) * 2005-12-07 2010-09-01 Nycomed Pharma AS Vorkompaktierte calciumhaltige zusammensetzungen
CN100391541C (zh) * 2006-03-16 2008-06-04 南台科技大学 以胶质类食材制造赋形剂的方法
AU2007232098A1 (en) * 2006-03-31 2007-10-11 Rubicon Research Private Limited Directly compressible composite for orally disintegrating tablets
EA030606B1 (ru) 2006-05-04 2018-08-31 Бёрингер Ингельхайм Интернациональ Гмбх Способы приготовления лекарственного средства, содержащего полиморфы
PE20080251A1 (es) 2006-05-04 2008-04-25 Boehringer Ingelheim Int Usos de inhibidores de dpp iv
EP1852108A1 (de) 2006-05-04 2007-11-07 Boehringer Ingelheim Pharma GmbH & Co.KG Zusammensetzungen von DPP-IV-Inhibitoren
CA2656181C (en) * 2006-06-27 2011-09-06 Daiichi Sankyo Company, Limited Compressed preparation of compositions comprising olmesartan medoxomil
WO2008079342A2 (en) * 2006-12-21 2008-07-03 Mallinckrodt Inc. Composition of and method for preparing orally disintegrating tablets
PE20140960A1 (es) 2008-04-03 2014-08-15 Boehringer Ingelheim Int Formulaciones que comprenden un inhibidor de dpp4
BRPI0916997A2 (pt) 2008-08-06 2020-12-15 Boehringer Ingelheim International Gmbh Inibidor de dpp-4 e seu uso
US20200155558A1 (en) 2018-11-20 2020-05-21 Boehringer Ingelheim International Gmbh Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral antidiabetic drug
JP5344938B2 (ja) * 2009-01-29 2013-11-20 旭化成ケミカルズ株式会社 崩壊性固形製剤
ES2760917T3 (es) 2009-11-27 2020-05-18 Boehringer Ingelheim Int Tratamiento de pacientes diabéticos genotipificados con inhibidores DPP-IV como la linagliptina
JP6034781B2 (ja) 2010-05-05 2016-11-30 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 併用療法
US9034883B2 (en) 2010-11-15 2015-05-19 Boehringer Ingelheim International Gmbh Vasoprotective and cardioprotective antidiabetic therapy
CN103946386B (zh) 2011-09-21 2018-01-02 株式会社林原 含有α,α‑海藻糖二水合物晶体的粉末的制备方法
US9522964B2 (en) * 2012-04-03 2016-12-20 Development, Inc. Micronized starch and methods for manufacturing same
EP3685839A1 (de) 2012-05-14 2020-07-29 Boehringer Ingelheim International GmbH Linagliptin zur verwendung in der behandlung von albuminuria und nierenbedingten erkrankungen
EP3556220A4 (de) 2017-10-03 2020-06-03 Mizkan Holdings Co., Ltd. Zusammensetzung mit lebensmittelmikropartikelkomplexen und verfahren zur herstellung davon

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4678812A (en) 1986-05-30 1987-07-07 E. I. Du Pont De Nemours And Company Trehalose as stabilizer and tableting excipient
US4762857A (en) 1986-05-30 1988-08-09 E. I. Du Pont De Nemours And Company Trehalose as stabilizer and tableting excipient
JP3069458B2 (ja) 1992-01-29 2000-07-24 武田薬品工業株式会社 口腔内崩壊型錠剤およびその製造法
DE627218T1 (de) 1992-02-18 1995-08-24 Nippon Shinyaku Co Ltd Schnelllösliche tablette.
JPH069382A (ja) * 1992-04-17 1994-01-18 Takeda Chem Ind Ltd 安定化された固型製剤およびその製造方法
DE69325700T2 (de) 1992-12-28 1999-12-30 Hayashibara Biochem Lab Nichtreduzierendes saccharidbildendes Enzym, und dessen Herstellung und Verwendungen
JP3773062B2 (ja) * 1993-01-29 2006-05-10 味の素株式会社 製剤用添加剤
JP3559585B2 (ja) * 1993-06-03 2004-09-02 株式会社林原生物化学研究所 トレハロース遊離酵素とその製造方法並びに用途
NZ278678A (en) 1994-01-31 1998-03-25 Yamanouchi Pharma Co Ltd Compressed moulded tablet with quick disintegration/dissolution in the mouth, mixture of low and high moldable saccharides as carriers
JP3534130B2 (ja) * 1994-03-01 2004-06-07 旭化成ケミカルズ株式会社 医薬品組成物
TW426737B (en) * 1994-06-27 2001-03-21 Hayashibara Biochem Lab Saccharide composition with reduced reducibility, and preparation and uses thereof
JP3616166B2 (ja) 1994-07-19 2005-02-02 株式会社林原生物化学研究所 トレハロースとその製造方法並びに用途
JP2919771B2 (ja) 1995-04-17 1999-07-19 佐藤製薬株式会社 速溶解性錠剤の製造方法及び該製造方法により製造した速溶解性錠剤
JP3418274B2 (ja) 1995-06-05 2003-06-16 日本化薬株式会社 口腔内感触の良好な錠剤
JPH0948726A (ja) 1995-08-07 1997-02-18 Tanabe Seiyaku Co Ltd 口腔内速崩壊性製剤およびその製法
CA2204599A1 (en) 1995-09-07 1997-03-13 Otsuka Pharmaceutical Co., Ltd. Low-pressure tableted effervescent preparation
JP3624038B2 (ja) * 1995-12-11 2005-02-23 株式会社林原生物化学研究所 糖衣固形物及びその製造方法
CN1213299A (zh) * 1996-02-09 1999-04-07 剑桥夸准脱控股有限公司 包含海藻糖的固体制剂
JPH09316006A (ja) 1996-05-29 1997-12-09 Yatsuken:Kk 口腔内溶解性固形製剤
ATE297191T1 (de) 1996-06-14 2005-06-15 Kyowa Hakko Kogyo Kk Im munde schnellzerfallende tablette
GB9616536D0 (en) * 1996-08-06 1996-09-25 Quadrant Holdings Cambridge Co-amoxiclav dosage form
JPH11116464A (ja) 1997-10-09 1999-04-27 Ss Pharmaceut Co Ltd 迅速溶解性固形製剤およびその製造法
TW527195B (en) * 1997-10-09 2003-04-11 Ssp Co Ltd Fast-soluble solid pharmaceutical combinations

Also Published As

Publication number Publication date
EP1097722A1 (de) 2001-05-09
CN1185013C (zh) 2005-01-19
US6699845B2 (en) 2004-03-02
ATE308343T1 (de) 2005-11-15
AU4651699A (en) 2000-02-07
EP1097722B1 (de) 2005-11-02
CN1309570A (zh) 2001-08-22
DE69928110T2 (de) 2006-07-27
WO2000003735A1 (fr) 2000-01-27
EP1097722A4 (de) 2002-03-20
KR20010071883A (ko) 2001-07-31
KR100421264B1 (ko) 2004-03-18
JP4748627B2 (ja) 2011-08-17
AU743109B2 (en) 2002-01-17
US20020042393A1 (en) 2002-04-11
CA2337015A1 (en) 2000-01-27
CA2337015C (en) 2004-09-07

Similar Documents

Publication Publication Date Title
DE69928110D1 (de) Trägerhilfstoff
GR3025639T3 (en) Porous inorganic ultrasound contrast agents
ATE419653T1 (de) Elektrolumineszierende anordnungen
MXPA04000849A (es) Composicion cristalina que contiene escitalopram.
DE69638015D1 (de) Pharmazeutischer Trägerstoff mit verbesserter Verpressbarkeit
SI1308170T1 (sl) Posušeni sestavek krvnega faktorja, ki obsega trehalozo
ZA963392B (en) Triggered active packagig material
BG101893A (en) Nodulosporic acid derivatives
NO20012249L (no) Faststoffsammensetning inneholdende D-mannitol og cerivastatin samt anvendelse av faststoffsammensetning forfremstilling av farmasöytisk preparat
DE69321519D1 (de) Pharmazeutische Anthocyanoside enthaltende Zusammensetzungen zur oralen Anwendung
DK0667155T3 (da) Tabletter med thioctsyre med bestemt kornstørrelse
NO952138D0 (no) Cefiximpreparat
FR2672070B1 (fr) Produit d'injection pour obturer des interstices, notamment pour la consolidation d'un terrain et autres applications.
TR200003413A3 (tr) Granüler organosilan hazir ürün, bunun üretimi için bir islem ve kullanimi
EP1043387B8 (de) Alkylbenzolsulfonat-Granulate
DE69703460D1 (de) Natriumpercarbonat und Verfahren zu dessen Herstellung
AU3856595A (en) Hydrate for drug use
FR2676888B1 (fr) Composition pour l'action contre des animaux nuisibles ou/et pour la modification de l'atmosphere ambiante, ainsi qu'un procede de sa preparation.
ITMI942076A0 (it) Procedimento per la riduzione del contenuto di nicotina mediante l'azione di microrganismi
ITPD920078A0 (it) Freno con amplificazione dell'effetto di frenata particolarmente per biciclette
IT1233220B (it) Dispositivo per l'abbattimento di particelle solide in sospensione in flussi d'aria, specialmente per applicazioni agricole
IT8902127A0 (it) Applicazione del principio di bernoulli e degli effetti derivati, per la realizzazione di giocattoli o mezzi pubblicitari
IT1278430B1 (it) Freno meccanico con amplificazione dell'effetto di frenata
BG107006U (en) Pravastatin-containing composition of a solid medicamentous form
IT9020696A1 (it) Varieta' di pinus nigra nano

Legal Events

Date Code Title Description
8364 No opposition during term of opposition